Diverse clinical outcomes of eosinophilic patients with T-cell receptor gene rearrangements : The emerging diagnostic importance of molecular genetics testingBUTTERFIELD, Joseph H.American journal of hematology. 2001, Vol 68, Num 2, pp 81-86, issn 0361-8609Article

Systemic mastocytosis : Clinical manifestations and differential diagnosisBUTTERFIELD, Joseph H.Immunology and allergy clinics of North America. 2006, Vol 26, Num 3, issn 0889-8561, vii, 487-513 [28 p.]Article

Bone marrow biopsies for the diagnosis of systemic mastocytosis: Is one biopsy sufficient?BUTTERFIELD, Joseph H; LI, Chin-Yang.American journal of clinical pathology. 2004, Vol 121, Num 2, pp 264-267, issn 0002-9173, 4 p.Article

Eosinophilic gastroenteritis and gluten-sensitive enteropathy in the same patientBUTTERFIELD, Joseph H; MURRAY, Joseph A.Journal of clinical gastroenterology. 2002, Vol 34, Num 5, pp 552-553, issn 0192-0790Article

Treatment of Hypereosinophilic Syndromes with Prednisone, Hydroxyurea, and InterferonBUTTERFIELD, Joseph H.Immunology and allergy clinics of North America. 2007, Vol 27, Num 3, issn 0889-8561, vii-viii, 493-518 [28 p.]Article

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D₂ ProductionBUTTERFIELD, Joseph H; WEILER, Catherine R.International archives of allergy and immunology. 2008, Vol 147, Num 4, pp 338-343, issn 1018-2438, 6 p.Article

Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuliKOBAYASHI, Hitoshi; GLEICH, Gerald J; BUTTERFIELD, Joseph H et al.Blood. 2002, Vol 99, Num 6, pp 2214-2220, issn 0006-4971Article

Urticaria and angioedema from cyclooxygenase-2 inhibitorsKELKAR, Pramod S; BUTTERFIELD, Joseph H; TEAFORD, Harry G et al.Journal of rheumatology. 2001, Vol 28, Num 11, pp 2553-2554, issn 0315-162XArticle

Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosisSMITH, Jonathan H; SNYDER, Melissa R; WEILER, Catherine R et al.Journal of allergy and clinical immunology. 2013, Vol 132, Num 4, pp 996-997, issn 0091-6749, 2 p.Article

Asthma treatment in a population-based cohort : Putting step-up and step-down treatment changes in contextYAWN, Barbara P; WOLLAN, Peter C; BERTRAM, Susan L et al.Mayo Clinic proceedings. 2007, Vol 82, Num 4, pp 414-421, issn 0025-6196, 8 p.Article

Treatment of asthma with nebulized lidocaine: A randomized, placebo-controlled studyHUNT, Loren W; FRIGAS, Evangelo; BUTTERFIELD, Joseph H et al.Journal of allergy and clinical immunology. 2004, Vol 113, Num 5, pp 853-859, issn 0091-6749, 7 p.Article

Neurologic symptoms and diagnosis in adults with mast cell diseaseSMITH, Jonathan H; BUTTERFIELD, Joseph H; PARDANANI, Animesh et al.Clinical neurology and neurosurgery (Dutch-Flemish ed.). 2011, Vol 113, Num 7, pp 570-574, issn 0303-8467, 5 p.Article

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyOGBOGU, Princess U; BOCHNER, Bruce S; ROTHENBERG, Marc E et al.Journal of allergy and clinical immunology. 2009, Vol 124, Num 6, pp 1319-1325, issn 0091-6749, 7 p.Article

Clostridium difficile toxins a and b directly stimulate human mast cellsMEYER, Gesa K. A; NEETZ, Anne; BRANDES, Gudrun et al.Infection and immunity. 2007, Vol 75, Num 8, pp 3868-3876, issn 0019-9567, 9 p.Article

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesVALENT, Peter; KLION, Amy D; BUTTERFIELD, Joseph H et al.Journal of allergy and clinical immunology. 2012, Vol 130, Num 3, pp 607-612, issn 0091-6749, 6 p.Article

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus ProposalVALENT, Peter; AKIN, Cem; NEDOSZYTKO, Boguslaw et al.International archives of allergy and immunology. 2012, Vol 157, Num 3, pp 215-225, issn 1018-2438, 11 p.Article

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosineLIM, Ken H; PARDANANI, Animesh; BUTTERFIELD, Joseph H et al.American journal of hematology. 2009, Vol 84, Num 12, pp 790-794, issn 0361-8609, 5 p.Article

The c-KIT mutation causing human mastocytosis is resistant to sti571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutationsYONGSHENG MA; SHAN ZENG; METCALFE, Dean D et al.Blood. 2002, Vol 99, Num 5, pp 1741-1744, issn 0006-4971Article

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsLIM, Ken-Hong; TEFFERI, Ayalew; LASHO, Terra L et al.Blood. 2009, Vol 113, Num 23, pp 5727-5736, issn 0006-4971, 10 p.Article

Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitisYAMAZAKI, Kiyoshi; MURRAY, Joseph A; ARORA, Amindra S et al.Digestive diseases and sciences. 2006, Vol 51, Num 11, pp 1934-1941, issn 0163-2116, 8 p.Article

Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell diseasePARDANANI, Animesh; REEDER, Terra L; KIMLINGER, Teresa K et al.Leukemia research. 2003, Vol 27, Num 8, pp 739-742, issn 0145-2126, 4 p.Article

Treatment of hypereosinophilic syndrome with imatinib mesilateGLEICH, Gerald J; LEIFERMAN, Kristin M; PARDANANI, Animesh et al.Lancet (British edition). 2002, Vol 359, Num 9317, pp 1577-1578, issn 0140-6736Article

Systemic mast cell disease without associated hematologic disorder: A combined retrospective and prospective studyPARDANANI, Animesh; BAEK, Jin-Young; LI, Chin-Yang et al.Mayo Clinic proceedings. 2002, Vol 77, Num 11, pp 1169-1175, issn 0025-6196, 7 p.Article